<DOC>
	<DOCNO>NCT00093977</DOCNO>
	<brief_summary>The purpose study determine whether darbepoetin alfa manufacture current `` roller bottle '' technology darbepoetin alfa manufacture serum free process comparable safety profile .</brief_summary>
	<brief_title>Study Assess Darbepoetin Alfa Subjects With Chronic Kidney Disease</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Darbepoetin alfa</mesh_term>
	<criteria>Currently diagnose Chronic Kidney Disease , either receive receive dialysis Anemic Currently erythropoietic therapy Controlled hypertension Clinically stable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Chronic Kidney Disease</keyword>
	<keyword>Dialysis</keyword>
	<keyword>Anemia</keyword>
	<keyword>Nephrology</keyword>
</DOC>